A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab

NCT04183608 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

238

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Adalimumab
DIAGNOSTIC_TEST: Calprotectin
OTHER: e-Monitoring
OTHER: Therapy Education

Sponsor

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

Collaborators

[object Object]